|
1
|
Sidaway P: Prostate cancer: New biomarker
panel prognosticates patient survival. Nat Rev Clin Oncol.
12:3102015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee BH, Kibel AS, Ciezki JP, Klein EA,
Reddy CA, Yu C, Kattan MW and Stephenson AJ: Are biochemical
recurrence outcomes similar after radical prostatectomy and
radiation therapy? Analysis of prostate cancer-specific mortality
by nomogram-predicted risks of biochemical recurrence. Eur Urol.
67:204–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chambers SK, Newton RU, Girgis A, Nielsen
L, Lepore S, Mihalopoulos C, Gardiner R, Galvão DA and Occhipinti
S: Living with prostate cancer: Randomised controlled trial of a
multimodal supportive care intervention for men with prostate
cancer. BMC Cancer. 11:3172011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawakami J, Cowan JE, Elkin EP, Latini DM,
DuChane J and Carroll PR: CaPSURE Investigators:
Androgen-deprivation therapy as primary treatment for localized
prostate cancer: Data from cancer of the prostate strategic
urologic research endeavor (CaPSURE). Cancer. 106:1708–1714. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Habl G, Uhl M, Katayama S, Kessel KA,
Hatiboglu G, Hadaschik B, Edler L, Tichy D, Ellerbrock M, Haberer
T, et al: Acute toxicity and quality of life in patients with
prostate cancer treated with protons or carbon ions in a
prospective randomized phase II Study-The IPI Trial. Int J Radiat
Oncol Biol Phys. 95:435–443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petersen SE, Bentzen L, Emmertsen KJ,
Laurberg S, Lundby L and Hoyer M: Development and validation of a
scoring system for late anorectal side-effects in patients treated
with radiotherapy for prostate cancer. Radiother Oncol. 111:94–99.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu B, Fukada K, Zhu H and Kyprianou N:
Prohibitin and cofilin are intracellular effectors of transforming
growth factor beta signaling in human prostate cancer cells. Cancer
Res. 66:8640–8647. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu LI, Fu NI, Luo XU, Li XY and Li XP:
Overexpression of cofilin 1 in prostate cancer and the
corresponding clinical implications. Oncol Lett. 9:2757–2761.
2015.PubMed/NCBI
|
|
9
|
Sundram V, Chauhan SC, Ebeling M and Jaggi
M: Curcumin attenuates β-catenin signaling in prostate cancer cells
through activation of protein kinase D1. PLoS One. 7:e353682012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dang D, Bamburg JR and Ramos DM:
Alphavbeta3 integrin and cofilin modulate K1735 melanoma cell
invasion. Exp Cell Res. 312:468–477. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Z, Li Y, Banerjee S, Kong D, Ahmad A,
Nogueira V, Hay N and Sarkar FH: Down-regulation of Notch-1 and
Jagged-1 inhibits prostate cancer cell growth, migration and
invasion, and induces apoptosis via inactivation of Akt, mTOR, and
NF-kappaB signaling pathways. J Cell Biochem. 109:726–736.
2010.PubMed/NCBI
|
|
12
|
Mirkheshti N, Park S, Jiang S, Cropper J,
Werner SL, Song CS and Chatterjee B: Dual targeting of androgen
receptor and mTORC1 by salinomycin in prostate cancer. Oncotarget.
7:62240–62254. 2016.PubMed/NCBI
|
|
13
|
Li CM, Narayanan R, Lu Y, Hurh E, Coss CC,
Barrett CM, Miller DD and Dalton JT:
2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual
pathways in cancer cells: 5′-AMP-activated protein kinase
(AMPK)/mTOR and PI3K/Akt/mTOR pathways. Int J Oncol. 37:1023–1030.
2010.PubMed/NCBI
|
|
14
|
Deeb D, Gao X, Dulchavsky SA and Gautam
SC: CDDO-me induces apoptosis and inhibits Akt, mTOR and NF-kappaB
signaling proteins in prostate cancer cells. Anticancer Res.
27:3035–3044. 2007.PubMed/NCBI
|
|
15
|
Lavie D: The functional groupings of
alpha-elaterin (cucurbitacin E). J Pharm Pharmacol. 10:7821958.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu YC, Huang TY and Chen MJ: Therapeutic
ROS targeting of GADD45γ in the induction of G2/M arrest in primary
human colorectal cancer cell lines by cucurbitacin E. Cell Death
Dis. 5:e11982014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yan M, Zhu L and Yang Q: Infection of
porcine circovirus 2 (PCV2) in intestinal porcine epithelial cell
line (IPEC-J2) and interaction between PCV2 and IPEC-J2
microfilaments. Virol J. 11:1932014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang WW, Yang JS, Lin MW, Chen PY, Chiou
SM, Chueh FS, Lan YH, Pai SJ, Tsuzuki M, Ho WJ and Chung JG:
Cucurbitacin E Induces G(2)/M Phase Arrest through STAT3/p53/p21
signaling and provokes apoptosis via Fas/CD95 and
mitochondria-dependent pathways in human bladder cancer T24 cells.
Evid Based Complement Alternat Med. 2012:9527622012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li J, Xiong M, Nadavaluru PR, Zuo W, Ye
JH, Eloy JD and Bekker A: Dexmedetomidine attenuates neurotoxicity
induced by prenatal propofol exposure. J Neurosurg Anesthesiol.
28:51–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Henning SM, Wang P, Said JW, Huang M,
Grogan T, Elashoff D, Carpenter CL, Heber D and Aronson WJ:
Randomized clinical trial of brewed green and black tea in men with
prostate cancer prior to prostatectomy. Prostate. 75:550–559. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong Y, Chen J, Zhou Z, Xia H, Qiu MH and
Chen C: Cucurbitacin E induces cell cycle G2/M phase arrest and
apoptosis in triple negative breast cancer. PLoS One.
9:e1037602014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duncan KL, Duncan MD, Alley MC and
Sausville EA: Cucurbitacin E-induced disruption of the actin and
vimentin cytoskeleton in prostate carcinoma cells. Biochem
Pharmacol. 52:1553–1560. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shan XL, Zhou XY, Yang J, Wang YL, Deng YH
and Zhang MX: Inhibitory effect of cucurbitacin E on the
proliferation of ovarian cancer cells and its mechanism. Chin J
Cancer. 29:20–24. 2010.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakashima S, Matsuda H, Kurume A, Oda Y,
Nakamura S, Yamashita M and Yoshikawa M: Cucurbitacin E as a new
inhibitor of cofilin phosphorylation in human leukemia U937 cells.
Bioorg Med Chem Lett. 20:2994–2997. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu W and Li Y: Salinomycin suppresses LRP6
expression and inhibits both Wnt/β-catenin and mTORC1 signaling in
breast and prostate cancer cells. J Cell Biochem. 115:1799–1807.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yun SM, Jung JH, Jeong SJ, Sohn EJ, Kim B
and Kim SH: Tanshinone IIA induces autophagic cell death via
activation of AMPK and ERK and inhibition of mTOR and p70 S6K in
KBM-5 leukemia cells. Phytother Res. 28:458–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Brown RE, Zotalis G, Zhang PL and Zhao B:
Morphoproteomic confirmation of a constitutively activated mTOR
pathway in high grade prostatic intraepithelial neoplasia and
prostate cancer. Int J Clin Exp Pathol. 1:333–342. 2008.PubMed/NCBI
|
|
28
|
Evren S, Dermen A, Lockwood G, Fleshner N
and Sweet J: Immunohistochemical examination of the mTORC1 pathway
in high grade prostatic intraepithelial neoplasia (HGPIN) and
prostatic adenocarcinomas (PCa): A tissue microarray study (TMA).
Prostate. 70:1429–1436. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zha QB, Zhang XY, Lin QR, Xu LH, Zhao GX,
Pan H, Zhou D, Ouyang DY, Liu ZH and He XH: Cucurbitacin E Induces
Autophagy via downregulating mTORC1 signaling and upregulating AMPK
activity. PLoS One. 10:e01243552015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han MA, Min KJ, Woo SM, Seo BR and Kwon
TK: Eupafolin enhances TRAIL-mediated apoptosis through cathepsin
S-induced down-regulation of Mcl-1 expression and AMPK-mediated Bim
up-regulation in renal carcinoma Caki cells. Oncotarget.
7:65707–65720. 2016.PubMed/NCBI
|
|
31
|
Sun C, Zhang M, Shan X, Zhou X, Yang J,
Wang Y, Li-Ling J and Deng Y: Inhibitory effect of cucurbitacin E
on pancreatic cancer cells growth via STAT3 signaling. J Cancer Res
Clin Oncol. 136:603–610. 2010. View Article : Google Scholar : PubMed/NCBI
|
